← FDA Drug Approvals (Drugs@FDA)

TADALAFIL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2026-05-15

Drug application

FDA Application #

ANDA210329

Application type

Abbreviated New Drug Application (Generic)

Brand name

TADALAFIL

Generic name

Tadalafil

Active ingredients

TADALAFIL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

JUBILANT GENERICS

First approval

2026-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown